🏆 Deal of the Week · CW 18/2021
Neuroelectrics raised USD 17.5 million in a Series A round; the post-money valuation was not disclosed. The round was backed by Morningside and MassChallenge. The capital is earmarked to advance the company's non-invasive electrical brain stimulation platform for conditions including epilepsy and depression.
Neuroelectrics — key deal facts
| Company | Neuroelectrics |
| Founded | 2012 |
| Headquarters | Barcelona, Spain |
| Amount raised | USD 17,5M |
| Valuation | Remains Undisclosed |
| Round | Series A |
| Investors | Morningside (https://morningside.com/) MassChallenge (https://masschallenge.org/) |
| Sectors | AI |
Who invested in Neuroelectrics?
The round was co-led by Morningside (morningside.com) and MassChallenge (masschallenge.org). The pairing is notable: Morningside brings deep life-sciences capital experience, while MassChallenge is a globally recognized accelerator network with a track record of backing early-stage health-tech innovators. Together they provide Neuroelectrics with both growth capital and ecosystem access across the United States and Europe.
What does Neuroelectrics do?
Neuroelectrics is a Barcelona-based digital brain health company founded in 2012. It develops non-invasive hardware and software for monitoring and stimulating the brain, targeting neurological and psychiatric disorders such as epilepsy and depression. Its flagship products are the Enobio wireless EEG headset for brain monitoring and the Starstim hybrid device, which combines EEG recording with transcranial electrical stimulation. The company operates at the intersection of neuroscience, machine learning, and medical hardware, applying AI-driven personalisation to neuromodulation therapy.
Neuroelectrics valuation & multiples
No existing multiples figures were provided for this deal; a valuation-based EV/Sales or EV/EBITDA analysis cannot be constructed without a disclosed enterprise value. As comparable benchmarks become available, they will be added here. For sector-level trading and transaction multiples relevant to AI-enabled medical devices, visit the Venionaire DealMatrix AI and MedTech sector multiples pages.
Explore the benchmarks: Series A.
Frequently asked questions
How much did Neuroelectrics raise in its Series A?
Neuroelectrics raised USD 17.5 million in its Series A round, announced in May 2021.
What is Neuroelectrics's valuation?
The post-money valuation was not disclosed as part of this Series A transaction.
Who invested in Neuroelectrics?
The Series A was backed by Morningside and MassChallenge.
When was Neuroelectrics founded and where is it based?
Neuroelectrics was founded in 2012 and is headquartered in Barcelona, Spain.
Source: original announcement — read the full report.